Unknown

Dataset Information

0

AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene.


ABSTRACT: Overexpression of the activator protein (AP)-2gamma transcription factor in breast tumours has been identified as an independent predictor of poor outcome and failure of hormone therapy. To understand further the function of AP-2gamma in breast carcinoma, we have used an RNA interference and gene expression profiling strategy with the MCF-7 cell line as a model. Gene expression changes between control and silenced cells implicate AP-2gamma in the control of cell cycle progression and developmental signalling. A function for AP-2gamma in cell cycle control was verified using flow cytometry: AP-2gamma silencing led to a partial G1/S arrest and induction of the cyclin-dependent kinase inhibitor, p21cip/CDKN1A. Reporter and chromatin immunoprecipitation assays demonstrated a direct, functional interaction by AP-2gamma at the CDKN1A proximal promoter. AP-2gamma silencing coincided with acquisition of an active chromatin conformation at the CDKN1A locus and increased gene expression. These data provide a mechanism whereby AP-2gamma overexpression can promote breast epithelial proliferation and, coupled with previously published data, suggest how loss of oestrogen regulation of AP-2gamma may contribute to the failure of hormone therapy in patients.

SUBMITTER: Williams CM 

PROVIDER: S-EPMC2782101 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7574879 | biostudies-literature
| S-EPMC3979034 | biostudies-literature
| S-EPMC3547831 | biostudies-literature
| S-EPMC8184824 | biostudies-literature
| S-ECPF-GEOD-36586 | biostudies-other
| S-EPMC4814324 | biostudies-literature
| S-EPMC4872753 | biostudies-literature
| S-EPMC6038146 | biostudies-literature
| S-EPMC6138935 | biostudies-literature
| S-EPMC5884656 | biostudies-literature